Methallylescaline (4-Methylallyloxy-3,5-dimethoxyphenethylamine) is a lesser-known
psychedelic drug. It is the 4-
methylanalog of
allylescaline. Methallylescaline was first synthesized by
Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 40–65 mg and the duration is listed as 12–16 hours.[2] Little data exists about the pharmacological properties, metabolism, and toxicity of methallylescaline, though it is known to be an agonist of 5-HT2A receptors, with effects comparable to that of other
mescaline analogs and has been sold as a
designer drug.[3][4]
Legal status
Methallylescaline is illegal in Sweden as of 26 January 2016.[5]
^Clare BW (2002). "QSAR of benzene derivatives: comparison of classical descriptors, quantum theoretic parameters and flip regression, exemplified by phenylalkylamine hallucinogens". Journal of Computer-aided Molecular Design. 16 (8–9): 611–33.
Bibcode:
2002JCAMD..16..611C.
doi:
10.1023/a:1021966231380.
PMID12602954.
S2CID9948738.
^Coelho Neto J (July 2015). "Rapid detection of NBOME's and other NPS on blotter papers by direct ATR-FTIR spectrometry". Forensic Science International. 252: 87–92.
doi:
10.1016/j.forsciint.2015.04.025.
PMID25965305.